SEC Form 4 · accession 0001102624-15-000219
Boston Therapeutics, Inc. · BTHE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Platt
Officer — CEO and Chairman · Director · 10% Owner
Period of report
Feb 12, 2015
Accepted (ET)
Feb 13, 2015 · 12:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001473579
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 12, 2015 | P | 250 | $0.51 | A | 7,545,735 | D |
Table II — derivative securities
No Table II lines on this filing.